JP2007508381A5 - - Google Patents

Download PDF

Info

Publication number
JP2007508381A5
JP2007508381A5 JP2006535493A JP2006535493A JP2007508381A5 JP 2007508381 A5 JP2007508381 A5 JP 2007508381A5 JP 2006535493 A JP2006535493 A JP 2006535493A JP 2006535493 A JP2006535493 A JP 2006535493A JP 2007508381 A5 JP2007508381 A5 JP 2007508381A5
Authority
JP
Japan
Prior art keywords
formulation
sildenafil
aerosolized
delivery device
aerosol delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006535493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007508381A (ja
Filing date
Publication date
Priority claimed from US10/685,746 external-priority patent/US7258850B2/en
Application filed filed Critical
Publication of JP2007508381A publication Critical patent/JP2007508381A/ja
Publication of JP2007508381A5 publication Critical patent/JP2007508381A5/ja
Pending legal-status Critical Current

Links

JP2006535493A 2003-10-14 2004-09-09 勃起障害治療のための方法および組成物 Pending JP2007508381A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/685,746 US7258850B2 (en) 1999-05-04 2003-10-14 Methods and compositions for treating erectile dysfunction
PCT/US2004/029374 WO2005039530A1 (en) 2003-10-14 2004-09-09 Methods and compositions for treating erectile dysfunction

Publications (2)

Publication Number Publication Date
JP2007508381A JP2007508381A (ja) 2007-04-05
JP2007508381A5 true JP2007508381A5 (https=) 2007-09-20

Family

ID=34520662

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006535493A Pending JP2007508381A (ja) 2003-10-14 2004-09-09 勃起障害治療のための方法および組成物

Country Status (5)

Country Link
US (3) US7258850B2 (https=)
EP (1) EP1677754A4 (https=)
JP (1) JP2007508381A (https=)
CA (1) CA2539845A1 (https=)
WO (1) WO2005039530A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258850B2 (en) * 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
US7235625B2 (en) 1999-06-29 2007-06-26 Palatin Technologies, Inc. Multiple agent therapy for sexual dysfunction
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
EP1750766B1 (en) * 2004-05-11 2013-07-03 Emotional Brain B.V. Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
BRPI0514410A (pt) * 2004-08-23 2008-06-10 Mannkind Corp fornecimento pulmonar de inibidores de fosfodiesterase do tipo 5
EP1790343A1 (en) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
EP1925307A1 (en) 2006-11-03 2008-05-28 Emotional Brain B.V. Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
WO2009091777A1 (en) * 2008-01-15 2009-07-23 Forest Laboratories Holdings Limited Nebivolol in the treatment of sexual dysfunction
EP2285362B1 (en) * 2008-06-19 2017-08-09 LTS LOHMANN Therapie-Systeme AG Composition for transdermal delivery of cationic active agents
WO2011156405A2 (en) * 2010-06-07 2011-12-15 Novadel Pharma Inc. Oral spray formulations and methods for administration of sildenafil
US20160151275A1 (en) * 2014-06-16 2016-06-02 James Kevin Shurtleff Method and devices for manufacturing and delivering of aerosolized formulations
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63500175A (ja) * 1985-05-22 1988-01-21 リポソ−ム テクノロジ−,インコ−ポレイテツド リポソ−ム吸入法および吸入システム
GB9114760D0 (en) 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
DK0567271T3 (da) 1992-04-20 1998-02-16 Sankyo Co Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf
US5756071A (en) 1992-06-03 1998-05-26 Arrowdean Limited Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
JPH06211675A (ja) 1993-01-11 1994-08-02 Shiro Tezuka 山椒入り局部塗付液
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
WO1995028930A1 (en) * 1994-04-22 1995-11-02 Pentech Pharmaceuticals, Inc. Dosage forms and method for ameliorating male erectile dysfunction
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
AU5719798A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
CA2277801C (en) 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
JP2001511160A (ja) 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US5877216A (en) * 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
DE69831421T2 (de) * 1997-12-02 2006-06-22 Archimedes Development Ltd. Zusammensetzungen zur nasalen verabreichung
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
US6455564B1 (en) 1999-01-06 2002-09-24 Pharmacia & Upjohn Company Method of treating sexual disturbances
US20010053780A1 (en) * 1999-04-30 2001-12-20 Whitaker John S. Daily treatment for erectile dysfunction using a PDE5 inhibitor
US7258850B2 (en) * 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
US6632419B2 (en) * 1999-05-04 2003-10-14 Aradigm Corporation Increasing libido in humans via acute testosterone administration
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
TWI224966B (en) 1999-11-02 2004-12-11 Pfizer Pharmaceutical composition (I) useful for treating or preventing pulmonary hypertension in a patient
GB0021487D0 (en) * 2000-09-01 2000-10-18 Pfizer Ltd Pharmaceutical
US20030119714A1 (en) 2000-12-15 2003-06-26 Naylor Alasdair Mark Treatment of male sexual dysfunction
JP2005503425A (ja) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
WO2004022128A2 (en) * 2002-09-06 2004-03-18 Chrysalis Technologies Incorporated Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation

Similar Documents

Publication Publication Date Title
JP2007508381A5 (https=)
JP2007500210A5 (https=)
EP4393477A3 (en) Compositions, methods and systems for aerosol drug delivery
WO2001073431A3 (en) Biomedical assay device
JP2004536805A5 (https=)
RU2008130763A (ru) Сублингвальный аэрозоль на основе фентанила
JP4190732B2 (ja) 抗真菌活性化合物を含む経口医薬組成物およびその製法
WO2009151572A3 (en) Compositions containing a solvated active agent suitable for dispensing as a compressed gas aerosol
JP2008521788A5 (https=)
CA2561109A1 (en) Gastric retention system
WO2006017341A3 (en) Coated vaginal devices for vaginal delivery of therapeutically effective and/ or health-promoting agents
JP2010532672A5 (https=)
NZ602968A (en) Extended release formulation containing a wax
WO2009154810A3 (en) Delivery systems for multiple active agents
IS2856B (is) Lyfjablanda úr ómeprasól
EA200970348A1 (ru) Новые инъецируемые депо-композиции и способ получения таких композиций
MY150611A (en) P38 map kinase inhibitors
TW201236816A (en) A blasting material and a blasting method
RS51313B (sr) Retard tablete sa hidromorfonom
WO2000040205A3 (en) Sustained release formulation with reduced moisture sensitivity
GB2389152A (en) Dispensing means
JP2009519350A5 (https=)
WO2008013833A3 (en) Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles
IT1317720B1 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
Kotlińska et al. Memantine and ACPC affect conditioned place preference induced by cocaine in rats